Dosing of proton pump inhibitors is suboptimal among otolaryngologists treating reflux-induced upper-respiratory disease

Abstract

Objective

To evaluate the practice of otolaryngologists treating reflux-induced upper-respiratory disease in a nationwide survey.

STUDY DESIGN

Survey study using an anonymous questionnaire containing clinical vignettes.

SUBJECTS AND METHODS

The survey was mailed to all 6,899 board-certified fellow members in practice in the American Academy of Otolaryngology–Head and Neck Surgery residing in the United States.

RESULTS

One thousand seven hundred twenty questionnaires were returned. Respondents empirically treated reflux-induced upper-respiratory disease with proton pump inhibitors once daily and twice daily 63% and 31%, respectively. Fifteen percent did not instruct their patients on how to take the proton pump inhibitors. Of those who instructed their patients, 22% advised dosing before breakfast, 32% before breakfast and again before dinner, and 46% recommended other timings. When prescribing twice-per-day dosing, 64% responded to give before breakfast and dinner and 28% responded before breakfast and at bedtime.

CONCLUSION

Suboptimal dosing of proton pump inhibitors is prevalent among otolaryngologists treating reflux-induced upper-respiratory disease.